Evidence map›Paper›PMID 30473712›Full record

ArticleAllergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology2018

The clinical burden of allergic rhinitis in five Middle Eastern countries: results of the SNAPSHOT program.

Ahmed Al-Digheari, Bassam Mahboub, Hesham Tarraf, Taskin Yucel, Isabella Annesi-Maesano, Adam Doble, Aaicha Lahlou, Luqman Tariq, Fayaz Aziz, Abdelkader El Hasnaoui

4 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04957927 phase4unknown statusnot on this mapstarted 2020, after this paper: background citation

Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age

TypeinterventionalSponsorUsama AzharRan2020 to 2021Enrolled60ConditionsAllergic RhinitisArmsEffectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age
NCT06427577 narecruitingnot on this mapstarted 2024, after this paper: background citation

Study on the Mechanism of ZhenQiFuZheng in the Treatment of Allergic Rhinitis Based on Intestinal Flora and Metabolites

TypeinterventionalSponsorThe First Affiliated Hospital with Nanjing Medical UniversityRan2024 to 2028Enrolled40ConditionsRhinitis, AllergicArmsZhenQi FuZheng granules (ShiDaiYangGuang)
NCT06709079 nanot yet recruitingnot on this mapstarted 2024, after this paper: background citation

Study on the Effect and Mechanism of Aescine Sodium in the Treatment of Allergic Rhinitis

TypeinterventionalSponsorCheng LeiRan2024 to 2026Enrolled60ConditionsAllergic RhinitisArmsAescine Sodium Tablets (Ocai®, Green Leaf Pharmaceuticals)
NCT06709092 narecruitingnot on this mapstarted 2024, after this paper: background citation

Study on the Effect and Mechanism of Lupatadine Fumarate in the Treatment of Allergic Rhinitis

TypeinterventionalSponsorCheng LeiRan2024 to 2026Enrolled60ConditionsAllergic RhinitisArmslupatadine fumarate (Luso®, Yangzijiang Pharmaceuticals)
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Clinical Practice Guideline: Immunotherapy for Inhalant Allergy.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2024
    Guideline
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Executive Summary of Clinical Practice Guideline on Immunotherapy for Inhalant Allergy.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2024
    Article
  8. Article
  9. Airways Type-2 Related Disorders: Multiorgan, Systemic or Syndemic Disease?International journal of molecular sciences · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. ARIA 2019 Care Pathways for Allergic Rhinitis in the Kuwait Health Care System.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2021
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 5 countries.

Ahmed Al-Digheari1Department of Paediatrics, Allergy And Clinical Immunology, Security Forces Hospital, Ministry of Interior, Riyadh, Saudi Arabia.
Bassam Mahboub2College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Hesham Tarraf4The Medical School, Cairo University, Cairo, Egypt.
Taskin Yucel5Department of Otorhinolaryngology, Hacettepe University, Ankara, Turkey.
Isabella Annesi-Maesano6Epidemiology of Allergic and Respiratory Diseases Department (EPAR), Institut Pierre Louis d'Epidemiologie et de Sante Publique (IPLESP), Sorbonne Universite and INSERM, Medical School Saint-Antoine, Paris, France.
Adam DobleFoxymed, Paris, France.
Aaicha LahlouMS Health, Rabat, Morocco.
Luqman TariqGlaxoSmithKline, PO Box 50199, Dubai, United Arab Emirates.
Fayaz AzizGlaxoSmithKline, PO Box 50199, Dubai, United Arab Emirates.
Abdelkader El HasnaouiGlaxoSmithKline, PO Box 50199, Dubai, United Arab Emirates.ORCID 0000-0002-1059-5875
Cairo University · EGHacettepe University · TRInserm · FRRashid Hospital · AESecurity Forces Hospital · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe SNAPSHOT program provides current data on the allergic rhinitis burden in the adult general population of five Middle Eastern countries (Egypt, Turkey, Kuwait, Saudi Arabia and the United Arab Emirates, the latter three grouped into a Gulf cluster).

methodsA multi-country, cross-sectional, epidemiological program conducted by telephone in a random sample of the adult general population; quotas were defined per country demographics. Subjects were screened for allergic rhinitis using the Score For Allergic Rhinitis questionnaire. Current prevalence (last 12 months) was estimated. Disease severity and control were assessed using the Allergic Rhinitis and its Impact on Asthma classification and Rhinitis Control Assessment Test respectively. Quality of sleep, impact on daily activities and quality of life were measured using the Epworth Sleepiness Scale, Sheehan Disability Scale and EuroQol Five-Dimension questionnaire respectively. Multivariate logistic regression analyses were used to investigate risk factors and co-morbidities.

results1808 of 33,486 subjects enrolled in the SNAPSHOT program fulfilled the case definition for allergic rhinitis. Prevalence was 3.6% [95% CI 3.2-4.0%] in Egypt, 6.4% [95% CI 5.9-6.9%] in Turkey and 6.4% [95% CI 6.0-6.9%] in the Gulf cluster. Risk factors identified were country, co-morbid asthma and income. Subjects with allergic rhinitis reported a significantly lower quality of life compared to the general population (

conclusionsAlthough the observed prevalence of allergic rhinitis in these Middle Eastern countries is low compared to western countries, its burden is considerable. Allergic rhinitis in general, and specifically uncontrolled and severe disease, results in a negative impact on quality of life, quality of sleep and daily activities.

Indexed as

Allergic rhinitisClinical burdenMiddle EastQuality of lifeSNAPSHOT

Identifiers

PMID30473712
PMCPMC6240937
OpenAlexW2896570423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.